AGP Picks
View all

Alexander Hughes flags AI talent gap in European pharma

Nov. 16, 2026
Alexander Hughes flags AI talent gap in European pharma
By AI, Created 22:50 UTC, Nov 16, 2026, AGP -

Alexander Hughes says European pharmaceutical companies need a new mix of AI, data, and industry expertise to move artificial intelligence from pilots into day-to-day use. The firm’s new article lays out ways to close the gap through internal development, targeted hiring, and partnerships.

Why it matters: - European pharmaceutical companies are trying to move artificial intelligence from pilot projects into routine research and manufacturing. - The main obstacle is not only technology. It is finding people who can combine pharma expertise, data skills, and sound judgment in regulated environments. - The issue affects how fast companies can scale AI and who will own decisions as adoption expands.

What happened: - Alexander Hughes published insights from an article titled “The Silent Bottleneck and the Purple Squirrel.” - The article examines why European pharmaceutical companies can struggle to turn AI pilots into everyday use. - The firm says the talent challenge spans both research and manufacturing.

The details: - The article says pharmaceutical companies need leaders who can connect industry knowledge with AI and data capabilities. - The article also points to the need for people who can manage change across teams and operations in regulated settings. - In executive search, a “purple squirrel” means a candidate with an unusually rare combination of qualifications. - The article recommends identifying skill gaps before launching a search. - It outlines three ways to close those gaps: develop current employees, recruit selectively for hard-to-build expertise, and use partnerships to support implementation. - The article also highlights a clear AI strategy, faster hiring, and succession planning as ways to attract and retain needed talent. - The piece says there are six actions outlined in the paper. - The article positions the guidance as a starting point for pharmaceutical executives and HR leaders reviewing which roles will support broader AI use.

Between the lines: - The article suggests the talent problem is a scaling problem, not a proof-of-concept problem. - European pharma may already have AI pilots, but the harder work is building the operating model and leadership bench to sustain them. - Faster hiring and succession planning matter because AI adoption can stall if companies cannot quickly fill specialized roles.

What's next: - Pharmaceutical companies can use the article’s framework to map current gaps and decide which capabilities to build internally versus hire externally. - Alexander Hughes is directing inquiries about AI talent and executive search in life sciences to Borries Von Müller, Client Partner at Alexander Hughes Germany. - The firm says its Life Sciences practice recruits senior leaders across research and development, regulatory affairs, and manufacturing. - More information is available on Alexander Hughes' LinkedIn page.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

The German Herald

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The German Herald

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.